Primary and secondary prevention of atherosclerosis: Is there a role for antioxidants?

Diabetes and Metabolism

Volumn 25, Issue 4, 1999, Pages 298-306

  Paolisso, G ^a   Esposito, R ^b   D'Alessio, M A ^b   Barbieri, M ^a  

^a Servizio di Astanteria Medica   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Antioxidant trace elements; Antioxidant vitamins; Atherosclerosis; Diabetes; Hyperglycaemia; Insulin resistance

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; COPPER; FATTY ACID; FREE RADICAL; IRON; PROBUCOL; RETINOL; SELENIUM; TRACE ELEMENT; ZINC;

AGING; ATHEROSCLEROSIS; CANCER; CLINICAL TRIAL; DIABETES MELLITUS; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; ISCHEMIC HEART DISEASE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIMARY PREVENTION; REVIEW; SECONDARY PREVENTION;

ANTIOXIDANTS; ARTERIOSCLEROSIS; DIABETES COMPLICATIONS; FREE RADICALS; HUMANS; HYPERGLYCEMIA; HYPERINSULINISM; INSULIN RESISTANCE; OXIDATIVE STRESS;

EID: 0032729731     PISSN: 03381684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. Cross CE, Halliwell B, Borish ET. Oxygen radicals and human disease. Ann Intern Med, 1987, 107, 526-545.
2. Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care, 1996, 19, 257-267.
3. Paolisso G, Giugliano D. Oxidative stress and insulin action: is there a relationship? Diabetalogia, 1996, 39, 357-363.
4. Cohen RA. Dysfunction of vascular endothelium in diabetes mellitus. Circulation, 1993, 87 (Suppl. 5), 67-76.
5. Ceriello A. Coagulation activation in diabetes mellitus: the role of hyperglycemia and therapeutic prospects. Diabetologia, 1993, 36, 1119-1125.
6. Hunt JV, Dean RT, Wolff SP. Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and aging. Biochem J, 1988, 256, 205-212.
7. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation and products in tissue and biochemical basis of diabetic complication. N Engl J Med. 1988, 318, 1315-1322.
8. Hohman TC, Beg MA. Diabetic complication: progress in the development of treatments. Exp Opin Invest Drugs, 1994, 3, 1041-1049.
9. Lowenstein CJ, Dinerman JL, Snyder SH. Nitric oxide: a physiologic messenger. Ann Intern Med, 1994, 120, 227-237.
10. Chari SN, Noth N, Rothi AD. Glutathione and its redox system in diabetic polymorfonuclear leucocytes. Am J Med Sci, 1984, 287, 14-15.
11. Lefebvre PJ, Scheen AJ. The postprandial state and risk of cardiovascular disease. Diabet Med 1998, 15 (Suppl 4), S63-8.
12. Ceriello A. Acute hyperglycaemia and oxidative stress generation. Diabet Med, . 1997, 14 (Suppl 3), S45-49.
13. Ceriello A, Bortolotti N, Motz E et al. Meal-generated oxidative stress in type 2 diabetic patients. Diabetes Care, 1998, 21, 1529-1533.
14. De Fronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension and atherosclerotic cardiovascular disease. Diabetes Care, 1991, 14, 173-194.
15. 2 generating system that is activated by insulin via a mechanism bypassing the receptor kinase. J Clin Invest, 1992, 89, 1006-1013.
16. Habib MP, Dickerson FD, Mooradian AD. Effect of diabetes, insulin and glucose load on lipid peroxidation in the rat. Metabolism, 1994, 43, 1442-1445.
17. Singal PK, Beamish RE, Dhalla NS. Potential oxidative pathways of cathecolamines in the formation of lipid peroxides and genesis of heart disease. Adv Exp Med Biol. 1983, 161, 391-401.
18. Dianzani NW. Free radicals and aging. In: "F Fabris, Pernigotti, E Ferrario eds. "Sedentary Life and Nutrition". Raven Press: New York, 1990, 27-37.
19. Rudich A, Tirosh A, Khamaisi M., Pessler D, Potashnik R, Bashan N. Putative role of oxidative stress in adipocyte and skeletal muscle insulin resistance. Diabetologia, 1998, 41, (Suppl)A34 (Abstract)
20. Kanety H, Hemi R, Paz K, Karasik A. Cellular stress impairs insulin signalling. Diabetologia, 1998, 41, (Suppl), A34 (Abstract)
21. Wolff SP, Jiang ZY, Hunt JV. Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Radic Biol Med, 1991, 10, 339-352.
22. Klip A, Volchuk A, Ramial T. Glucose transporters of muscle cells in culture. Development regulation and modulation by lipoic acid, and anti-hyperglycemic agent. In:Draznin B and Le Roith D, eds. "Molecular biology of diabetes, insulin action, effects on gene expression and regulation, and glucose transport". Vol.2, Ttowa: NJ Humana, 1994, 511-528.
23. Khamaisi M, Potashnik R, Tirsoh A et al. Lipoic acid reduces glycemia and increases muscle GLUT 4 content in streptozotocin-diabetic rats. Metabolism. 1997, 46, 763-768.
24. Paolisso G., Di Maro G., Galzerano D et al. Pharmacological doses of vitamin E and insulin action in elderly subjects. AMJ Clin Nutr, 1994, 59, 1291-1296.
25. Paolisso G, Gambardella A, Giugliano D et al. Chronic intake of pharmacological doses of vitamin E might be useful in the therapy of elderly patients with coronary heart disease. Am J Clin Nutr, 1995, 61, 848-852.
26. Paolisso G, Tagliamonte MR, Rizzo MR, Manzella D, Gambardella A, Varricchio M. Oxidative stress and advancig age: results in healthy centenarians. J Am Geriatric Soc. 1998, 46, 833-838
27. Yasunari K, Kohno M, Kano H, Yokokawa K, Minami M, Yoshikawa J. Antioxidants improve impaired insulin-mediated glucose uptake and prevent migration and proliferation of cultured rabbit coronary smooth muscle cells induced by high glucose. Circulation, 1999, 99, 1370-1378.
28. Vincent HK, Powers SK, Stewart DJ, Shanely RA, Demirel H, Naito H. Obesity is associated with increased myocardial oxidative stress. Int. J.Obes Relat Metab Disord, 1999, 23, 67-74.
29. Strauss RS. Comparison of serum concentration of alpha-tocopherol and beta-carotene in a cross-sectional sample of obese and nonobese children (NHANES 111). National Health and Nutrition Examination Survey. J Pediatr, 1999, 134, 160-165.
30. Bussiere L, Mazur A, Gueux E, Nowacki W, Rayssiguier Y. Triglyceride-rich lipoproteins from magnesium-deficient rats are more susceptible to oxidation by cells and promote proliferation of cuitured vascular smooth muscle cells. Magnes Res, 1995, 8, 151-157.
31. Mosinger BJ. Higher cholesterol in human LDL is associated with the increase of oxidation susceptibility and the decrease of antioxidant defence: experimental and simulation data. Biochim Biophys Acta, 1999, 1453, 180-184.
32. Heinecke JW. Oxidants and antioxidants in the pathogenesis of atherosclerosis: implication for the oxidized low density lipoprotein hypothesis. Atherosclerosis, 1998, 141, 1-15.
33. Masoro EJ. Influence of caloric intake on aging and on the response to stressors. J Toxicol Environ Health B Crit Rev, 1998, 1 (3), 243-257
34. Diaz MN, Frei B., Vita JA, Keaney JF. Antioxidants and atherosclerotic heart diseases. N Engl J Med, 1997, 337, 481-487.
35. Tang XL, Kaur H, Sun JZ et al. Effect of the hydrophilic alphatocopherol analog MDL 74,405 on detection of hydroxyl radicals in stunned myocardium in dogs. Am Heart J, 1995, 130, 940-948
36. Ting HH, Timini FK, Haley EA, Roddy MA, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia. Circulation, 1997, 95, 2617-2622.
37. Solzbach U, Horning B, Jeserich M, Just H. Vitamin C improves endothelial dysfunction of epicardial coronary arteries in hypertensive patients. Circulation, 1997, 96, 1513-1519.
38. Heitzer T, Yla Herttuala S, Wild E, Luoma J. Drexler H. Effect of vitamin E on endothelial vasodilator function in patients with hypercholesterolemia, chronic smoking or both. J Am Coll Cardiol, 1999, 33, 499-505.
39. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med, 1993, 328, 1444-1449.
40. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Golditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med, 1993, 328, 1450-1456.
41. Knekt P, Reunanen A, Jarvinen R, Seppanen R, Heliovaara M, Aromaa A. Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am J Epidemiol, 1994, 139, 1180-1190.
42. Kushi LH, Folsom AR, Prineas RJ, Mink PJ, Ying W, Bostick RM. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med, 1996, 334, 1156-1162.
43. Morris DL, Krichevsky SB, Davis CE. Serum carolenoids and coronary heart disease. The Lipid Research Clinics Coronary Primary Prevention Trial and Follow-up. JAMA, 1994, 272, 1439-1441.
44. Klipstein-Grobush K, Geleijnse JM, den Breeijen JH et al. Dietary antioxidants and risk of myocardial infarction in the elderly: the Rotterdam Study. Am J Clin Nutr, 1999, 69, 261-266.
45. Enstrom JE, Kanim LE, Klein MA. Vitamin C intake and mortality among a sample of the United States population. Epidemiology, 1992, 3, 194-202.
46. Gale CR, Martyn CN, Winter PD, Cooper C. Vitamin C and risk of death from stroke and coronary heart disease in a cohort of elderly people. BMJ, 1995, 310, 1563-1566.
47. Stephens NG, Parsons A, Schofield PM et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet, 1996, 347, 781-786.
48. Azen SP, Qian D, Mack WJ et al. Effect of Supplementary Antioxidant Vitamin Intake on Carotid Arterial Wall Intima-Media Thickness in a Controlled Clinical Trial of Cholesterol Lowering. Circulation, 1996, 94, 2369-2372.
49. Tardif J-C, Cote G, Lesperance J et al. Probucol and multivitamins in the prevention of restenosis after coronary angiopiasty. Multivitamins and Probucol Study Group. N Engl J Med, 1997, 337, 365-372.
50. Yokoi H, Daida H, Kuwabara Y et al. Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty: the Probucol Angioplasty Restenosis Trial. J Am Coll Cardiol, 1997, 30, 855-862.
51. Tomoda H, Yoshitake M, Morimoto K, Aoki N. Possible prevention of post-angioplasty restenosis by ascorbic acid. Am J Cardiol, 1996, 78, 1284-1286.
52. De Maio SJ, King SB III, Lembo NJ et al. Vitamin E supplementation, plasma lipids and incidence of restenosis after percutaneous transluminal coronary angioplasty (PTCA). J Am Coll Nutr, 1992, 11, 68-73.
53. Rapola JM, Virtamo J, Ripatti S, Huttunen JK, Albanes D, Taylor PR, Heinonen OP. Randomised trial of α-tocopherol and β-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet, 1997, 349, 1715-1720.
54. Omenn GS, Goodman GE, Thornquist MD et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med, 1996, 334, 1150-1155.
55. Jones AF, Winkles JW, Jennings PE, Florkowski CM, Lunec J, Barneit AH. Serum antioxidant activity in diabetes mellitus. Diabetes Res, 1988, 7, 89-92.
56. Reaven PD, Herold DA, Barnett J, Edelman S. Effects of Vitamin E on susceptibility of low-density lipoprotein and low-density lipoprotein subfraction to oxidation and on protein glycation in NIDDM. Diabetes Care, 1995, 18, 807-816.
57. Yoshida H, Ishikawa T, Nakamura H. Vitamin E/lipid peroxide ratio and susceptibility of LDL to oxidative modification in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol, 1997, 17, 1438-1446.
58. Osterode W, Holler C, Ulberth F. Nutritional antioxidants, red cell membrane fluidity and blood viscosity in type 1 (insulin-dependent) diabetes mellitus. Diabet Med, 1996, 13, 1044-1050.
59. Ryan TP, Aust SD. The role of iron in oxygen-mediated toxicities. Crit Rev Toxicol, 1992, 22, 119-141
60. Corti MC, Graziano M, Hennekens CH. Iron status and risk of cardiovascular disease. Ann Epidemiol, 1997, 7, 62-68.
61. Lee TS, Shiao MS, Pan CC, Chau LY. Iron-deficient diet reduces atherosclerotic lesions in apoE-deficient mice. Circulation, 1999, 99, 1222-1229.
62. Retsky KL, Chen K, Zeind J, Frei B. Inhibition of copper-induced LDL oxidation by vitamin C is associated with decreased copper-binding to LDL and 2-oxo-histidine formation. Free Radic Biol Med, 1999, 26, 90-98.
63. Iskra M, Patelski J, Majewski W. Relationship of calcium, magnesium, zinc and copper concentrations in the arterial wall and serum in atherosclerosis obliterans and aneurysm. J Trace Elem Med Biol, 1997, 11, 248-252.
64. Mazur A, Gueux E, Bureau I, Feillet-Coudray C, Rock E, Rayssiguier Y. Copper deficiency and lipoprotein oxidation. Atherosclerosis, 1998, 137, 443-445.
65. Henning B, Toborek M, Mcclain CJ. Antiatherogenic properties of zinc: implication in endothelial cell metabolism. Nutrition, 1996, 12, 711-717.
66. Dilsiz N, Olcucu A, Cay M, Naziroglu M, Cobanoglu D. Protective effects of selenium, vitamin C and vitamin E against oxidative stress of cigarette smoke in rats. Cell Biochem Funct, 1999, 17, 1-7.
67. Hughes K, Ong CN. Vitamins, selenium, iron, and coronary heart disease risk in Indians, Malays, and Chinese in Singapore. J Epidemiol Community Health, 1998, 52, 181-185.
68. Schwenke DC, Behr SR., Vitamin E combined with selenium inhibits atherosclerosis in hypercholesterolemic rabbits independently of effects on plasma cholesterol concentration. Circ Res, 1998, 83, 366-377.
69. Blot WJ, Li JY, Taylor PR et al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence and disease-specific mortality in the general population. J Natl Cancer Inst, 1993, 85, 1483-1492.
70. Tribble DL. Antioxidant Consumption and Risk of Coronary Heart Disease: Emphasis on Vitamin C, Vitamin E, and b Carotene. Circulation, 1999, 99, 591-595.